Diagnostic value of serum markers of connective tissue turnover for predicting histological staging and grading in patients with chronic hepatitis C

Journal of Gastroenterology

Volumn 36, Issue 6, 2001, Pages 399-406

  Murawaki, Y ^a   Ikuta, Y ^a   Okamoto, K ^a   Koda, M ^a   Kawasaki, H ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Chronic hepatitis C; Hyaluronan; MMP 2; PIVNP

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 4; GELATINASE A; HYALURONIC ACID; INTERSTITIAL COLLAGENASE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; BLOOD LEVEL; CONNECTIVE TISSUE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE MARKER; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER FIBROSIS; LIVER NECROSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAGING; TURNOVER TIME;

ADULT; AGED; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CONNECTIVE TISSUE; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; LIVER; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROCOLLAGEN; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0034934457     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170084     Document Type: Article

References (23)

1. The long-term pathological evolution of chronic hepatitis C
2. The natural course of chronic hepatitis C: A comparison between patients with genotypes 1 and 2 hepatitis C viruses
3. Natural history of hepatitis C
4. Relationship of aminotransferases to liver histological status in chronic hepatitis C
5. Relationships between serum aminotransferase levels, liver histologies and virological status in patients with chronic hepatitis C in Taiwan
6. Serum assays for liver fibrosis
7. Detection of hepatic fibrogenesis: A review of available techniques
8. Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: Relationship to liver histology
9. Serum matrix metalloproteinase-1 in patients with chronic viral hepatitis
10. Clinical significance of serum hyaluronan in patients with chronic viral liver disease
11. Clinical usefulness of serum matrix metalloproteinase-2 concentration in patients with chronic viral liver disease
12. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis
13. Classification of chronic hepatitis: Diagnosis, grading and staging
14. Measuring the accuracy of diagnostic systems
15. Diagnostic accuracy of hyaluronan and type III procollagen amino-terminal peptide serum assays as markers of liver fibrosis in chronic viral hepatitis C evaluated by ROC curve analysis
16. Serum hyaluronan as a marker of liver fibrosis
17. Serum markers for connective tissue turnover in patients with chronic hepatitis B and chronic hepatitis C: A comparative analysis
18. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C
19. Dual expression of matrix metalloproteinase-2 and membrane type1-matrix metalloproteinase in fibrotic human livers
20. Circulating matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 as serum markers of fibrosis in patients with chronic hepatitis C: Relationship to interferon response
21. Plasma levels of matrix metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) as noninvasive markers of liver disease in chronic hepatitis C: Comparison using ROC analysis
22. Heterogeneity of antigens related to 7S domain of type IV collagen in serum: Application to patients with chronic liver disease
23. Serum laminin and type III procollagen in chronic hepatitis C: Diagnostic value in the assessment of disease activity and fibrosis